FMCSA Seeks Comments on Seizure-Related Driver Exemption Requests
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
FMCSA is reviewing exemption requests from six people who want to drive commercial motor vehicles across state lines despite having epilepsy or another seizure-related condition. Current federal safety rules generally bar drivers with conditions that could cause loss of consciousness or loss of vehicle control. If approved, the exemptions would let these specific applicants operate commercial vehicles in interstate commerce while taking anti-seizure medication. Motor carriers, safety groups, medical professionals, and the public can submit comments by July 22, 2026.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- FMCSA has opened public comment on six individual exemption applications
- The requests concern commercial drivers with epilepsy or seizure-related conditions
- Approved exemptions would allow the named applicants to drive interstate commercial vehicles while using anti-seizure medication
Obligations
What this law requires
Persons with a clinical diagnosis of epilepsy or another condition likely to cause loss of consciousness or loss of ability to control a commercial motor vehicle may not drive commercial motor vehicles in interstate commerce unless granted an FMCSA exemption.
Comments on the exemption applications identified by Docket No. FMCSA-2026-0040 must be submitted to FMCSA by the stated comment deadline.
Commenters should submit comments using only one of the listed methods: regulations.gov, mail, hand delivery or courier, or fax, to avoid duplicate submissions.